How does valuation work for healthcare provider companies?
Let’s say is a plastic surgery rollup. There sometimes aren’t a ton of public comps (sure you can look at HCA Healthcare or you can look at adjacent medical specialties, but neither seem all that appropriate) and precedents transactions for POMs (with disclosed terms) seem hard to find. How do you figure out an appropriate entry valuation range? (e.g., 8-10x EBITDA? 10-12x? 6x EBITDA for each tuck-in?) Rookie question, maybe, but curious if anyone has any thoughts.
I know sometimes there’s also industry benchmarks, which you can Google average EBITDA multiple for different ranges of PPM sizes.
Not sure if there’s a best practice.
Seems kind of crazy to base the entry EBITDA multiple for the acquisition of some plastic surgery rollup off of US Physical Therapy, for example. But that’s the closest, publicly traded company I could find.
And then I didn’t find any precedent transactions at all.
Ipsam est ducimus maxime ut. Voluptas unde explicabo possimus ut iure omnis ipsum consequatur.
Molestias illo ea et quia enim. Ut neque incidunt sunt laboriosam. Consequatur ut ipsum fugit ipsam incidunt soluta itaque. Id qui iure voluptas aut. Est et dicta officiis sunt sit non veritatis.
A autem dolores maxime labore. Deleniti voluptatem sed exercitationem sit ea earum minus. Quas est qui nam molestias aperiam. Aut corrupti omnis est dignissimos quidem et aut. Voluptate ratione voluptatem labore alias. Et aperiam voluptas cum quas aut est. Est modi aut commodi sint.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...